Product Images Albuterol Sulfate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Albuterol Sulfate NDC 68071-5206 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 68071 5206 2

pdp - 68071 5206 2

This is a description of an asthma medication by NuCare Pharmaceuticals, Inc. The medication, which is only available by prescription, comes in the form of a metered inhaler with each actuation delivering 108mcg Albuterol Sulfate, equivalent to 90mcg Albuterol. The lot number for this medication is 000000. The manufacturer's NDC code is 45802-088-01 and the product's NDC code is 68071-5206-02. The medication should be kept at a controlled temperature of 68-77°F and out of reach of children. This information is not intended to be a full list of ingredients.*

chemical-structure - chemical structure

chemical-structure - chemical structure

figure-a-b.jpg - figure a b

figure-a-b.jpg - figure a b

The scanned document appears to be an image and not text. It is not readable.*

figure-c.jpg - figure c

figure-c.jpg - figure c

figure-d.jpg - figure d

figure-d.jpg - figure d

Albuterol Sulfate Inhalation Aerosol is a medication for inhalation that comes with 200 sprays for use and 3 additional sprays for priming purposes. This figure D shows that before priming the device, the spray counter will read 200 and after priming, it will read 203.*

figure-e.jpg - figure e

figure-e.jpg - figure e

figure-f.jpg - figure f

figure-f.jpg - figure f

figure-g-h.jpg - figure g h

figure-g-h.jpg - figure g h

figure-graphs - figure graphs

figure-graphs - figure graphs

This is a chart showing the percentage change in FEV over time in a clinical trial that lasted for 6 weeks. The trial included three groups: one group using albuterol sulfate inhalation aerosol, one group using a matched placebo HFA inhalation aerosol, and one group using a marketed HFA-134a albuterol inhaler. The chart shows the percentage change in FEV on Day 1 and Day 43.*

figure-i.jpg - figure i

figure-i.jpg - figure i

figure-j.jpg - figure j

figure-j.jpg - figure j

figure-k.jpg - figure k

figure-k.jpg - figure k

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.